Viemed Roic vs Ev To Sales Analysis

VMD Stock

USD 8.65 0.10 1.14%

Viemed Healthcare financial indicator trend analysis is much more than just breaking down Viemed Healthcare prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Viemed Healthcare is a good investment. Please check the relationship between Viemed Healthcare Roic and its Ev To Sales accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Viemed Healthcare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

For information on how to trade Viemed Stock refer to our How to Trade Viemed Stock guide.

Roic vs Ev To Sales

Roic vs Ev To Sales Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Viemed Healthcare Roic account and Ev To Sales. At this time, the significance of the direction appears to have pay attention.

The correlation between Viemed Healthcare's Roic and Ev To Sales is -0.81. Overlapping area represents the amount of variation of Roic that can explain the historical movement of Ev To Sales in the same time period over historical financial statements of Viemed Healthcare, assuming nothing else is changed. The correlation between historical values of Viemed Healthcare's Roic and Ev To Sales is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Roic of Viemed Healthcare are associated (or correlated) with its Ev To Sales. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ev To Sales has no effect on the direction of Roic i.e., Viemed Healthcare's Roic and Ev To Sales go up and down completely randomly.

Correlation Coefficient

-0.81

Relationship Direction	Negative
Relationship Strength	Significant

View All Relationships

Roic

Return on Invested Capital, a profitability ratio that measures the return that an investment generates for those who have provided capital, such as debt holders and equity holders.

Ev To Sales

The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.

Most indicators from Viemed Healthcare's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Viemed Healthcare current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Viemed Healthcare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

For information on how to trade Viemed Stock refer to our How to Trade Viemed Stock guide.At present, Viemed Healthcare's Enterprise Value Over EBITDA is projected to increase based on the last few years of reporting. The current year's Enterprise Value Multiple is expected to grow to 12.56, whereas Selling General Administrative is forecasted to decline to about 50.5 M.

	2021	2022	2023	2024 (projected)
Gross Profit	73.4M	84.7M	112.8M	65.9M
Total Revenue	117.1M	138.8M	183.0M	101.6M

Gross Profit Total Revenue

Viemed Healthcare fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Retained Earnings	Accounts Payable	Cash	Long Term Debt	Net Receivables	Inventory	Total Liab	Short Long Term Debt	Total Current Assets	Common Stock	Property Plant Equipment	Short Long Term Debt Total	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.95	0.91	0.99	0.94	0.99	0.69	0.81	0.87	0.95	0.82	0.86	0.17	0.94	0.89	0.99	0.25	0.99	0.54	-0.67	0.98	0.64	0.95
Other Current Liab	0.95		0.94	0.92	0.87	0.92	0.77	0.75	0.86	0.89	0.83	0.89	0.15	0.88	0.81	0.96	0.29	0.96	0.33	-0.58	0.91	0.52	0.86
Total Current Liabilities	0.91	0.94		0.85	0.81	0.84	0.84	0.67	0.87	0.85	0.73	0.98	0.1	0.8	0.74	0.92	0.51	0.92	0.46	-0.39	0.84	0.34	0.78
Total Stockholder Equity	0.99	0.92	0.85		0.94	1.0	0.64	0.82	0.82	0.95	0.84	0.77	0.14	0.95	0.91	0.97	0.11	0.97	0.54	-0.74	0.99	0.71	0.97
Net Tangible Assets	0.94	0.87	0.81	0.94		0.94	0.61	0.78	0.87	0.9	0.8	0.74	0.13	0.9	0.98	0.9	0.13	0.94	0.53	-0.65	0.96	0.61	0.95
Retained Earnings	0.99	0.92	0.84	1.0	0.94		0.62	0.86	0.81	0.94	0.82	0.77	0.15	0.97	0.9	0.96	0.12	0.97	0.51	-0.77	0.99	0.75	0.96
Accounts Payable	0.69	0.77	0.84	0.64	0.61	0.62		0.38	0.56	0.65	0.73	0.78	-0.35	0.53	0.54	0.72	0.28	0.7	0.26	-0.19	0.6	0.07	0.56
Cash	0.81	0.75	0.67	0.82	0.78	0.86	0.38		0.71	0.68	0.47	0.65	0.26	0.95	0.69	0.8	0.23	0.8	0.21	-0.88	0.81	0.88	0.73
Long Term Debt	0.87	0.86	0.87	0.82	0.87	0.81	0.56	0.71		0.82	0.57	0.89	0.39	0.81	0.84	0.88	0.53	0.91	0.51	-0.4	0.86	0.43	0.82
Net Receivables	0.95	0.89	0.85	0.95	0.9	0.94	0.65	0.68	0.82		0.82	0.78	0.2	0.87	0.89	0.93	0.17	0.94	0.65	-0.58	0.95	0.56	0.95
Inventory	0.82	0.83	0.73	0.84	0.8	0.82	0.73	0.47	0.57	0.82		0.59	-0.15	0.67	0.79	0.79	-0.16	0.79	0.43	-0.5	0.82	0.39	0.84
Total Liab	0.86	0.89	0.98	0.77	0.74	0.77	0.78	0.65	0.89	0.78	0.59		0.24	0.75	0.68	0.87	0.67	0.87	0.42	-0.3	0.78	0.29	0.71
Short Long Term Debt	0.17	0.15	0.1	0.14	0.13	0.15	-0.35	0.26	0.39	0.2	-0.15	0.24		0.23	0.17	0.14	0.49	0.18	0.13	-0.07	0.23	0.23	0.21
Total Current Assets	0.94	0.88	0.8	0.95	0.9	0.97	0.53	0.95	0.81	0.87	0.67	0.75	0.23		0.83	0.93	0.19	0.93	0.39	-0.84	0.94	0.83	0.88
Common Stock	0.89	0.81	0.74	0.91	0.98	0.9	0.54	0.69	0.84	0.89	0.79	0.68	0.17	0.83		0.85	0.09	0.89	0.6	-0.58	0.94	0.55	0.96
Property Plant Equipment	0.99	0.96	0.92	0.97	0.9	0.96	0.72	0.8	0.88	0.93	0.79	0.87	0.14	0.93	0.85		0.28	0.99	0.51	-0.64	0.95	0.62	0.92
Short Long Term Debt Total	0.25	0.29	0.51	0.11	0.13	0.12	0.28	0.23	0.53	0.17	-0.16	0.67	0.49	0.19	0.09	0.28		0.28	0.14	0.25	0.17	-0.16	0.08
Property Plant And Equipment Net	0.99	0.96	0.92	0.97	0.94	0.97	0.7	0.8	0.91	0.94	0.79	0.87	0.18	0.93	0.89	0.99	0.28		0.51	-0.63	0.97	0.61	0.94
Current Deferred Revenue	0.54	0.33	0.46	0.54	0.53	0.51	0.26	0.21	0.51	0.65	0.43	0.42	0.13	0.39	0.6	0.51	0.14	0.51		-0.11	0.56	0.18	0.63
Net Debt	-0.67	-0.58	-0.39	-0.74	-0.65	-0.77	-0.19	-0.88	-0.4	-0.58	-0.5	-0.3	-0.07	-0.84	-0.58	-0.64	0.25	-0.63	-0.11		-0.7	-0.97	-0.65
Net Invested Capital	0.98	0.91	0.84	0.99	0.96	0.99	0.6	0.81	0.86	0.95	0.82	0.78	0.23	0.94	0.94	0.95	0.17	0.97	0.56	-0.7		0.68	0.99
Net Working Capital	0.64	0.52	0.34	0.71	0.61	0.75	0.07	0.88	0.43	0.56	0.39	0.29	0.23	0.83	0.55	0.62	-0.16	0.61	0.18	-0.97	0.68		0.65
Capital Stock	0.95	0.86	0.78	0.97	0.95	0.96	0.56	0.73	0.82	0.95	0.84	0.71	0.21	0.88	0.96	0.92	0.08	0.94	0.63	-0.65	0.99	0.65

Click cells to compare fundamentals

Viemed Healthcare Account Relationship Matchups

Viemed Healthcare fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	82.6M	112.6M	118.0M	117.0M	154.9M	88.4M
Other Current Liab	9.1M	9.9M	8.4M	10.6M	14.3M	7.6M
Total Current Liabilities	25.9M	23.0M	17.8M	18.9M	32.1M	20.2M
Total Stockholder Equity	43.7M	81.7M	94.8M	97.1M	113.9M	62.9M
Other Liab	2.3M	859K	757K	889K	1.0M	816.6K
Net Tangible Assets	43.7M	81.7M	94.8M	97.1M	111.7M	117.2M
Retained Earnings	34.1M	65.6M	73.3M	69.8M	79.5M	48.6M
Accounts Payable	4.7M	2.1M	3.2M	2.7M	7.4M	3.9M
Cash	13.4M	31.0M	28.4M	16.9M	12.8M	15.3M
Non Current Assets Total	54.8M	65.4M	70.7M	77.3M	116.5M	122.4M
Non Currrent Assets Other	13K	863K	862K	1.6M	887K	842.7K
Other Assets	13K	9.6M	5.6M	4.7M	1.0	0.95
Long Term Debt	7.6M	5.8M	4.3M	6.0M	6.9M	7.2M
Cash And Short Term Investments	13.4M	31.0M	28.4M	16.9M	12.8M	15.0M
Net Receivables	11.5M	12.4M	14.7M	15.4M	18.5M	12.7M
Common Stock Total Equity	3.4M	9.2M	14.0M	15.1M	17.4M	18.3M
Common Stock Shares Outstanding	39.7M	40.5M	40.7M	39.8M	40.4M	38.7M
Long Term Debt Total	394K	10.7M	5.8M	4.3M	5.0M	3.9M
Liabilities And Stockholders Equity	82.6M	112.6M	118.0M	117.0M	154.9M	85.7M
Non Current Liabilities Total	13.0M	7.9M	5.3M	1.1M	8.9M	5.0M
Capital Surpluse	6.4M	7.3M	7.7M	12.1M	13.9M	14.6M
Capital Lease Obligations	10.1M	3.5M	732K	694K	3.3M	2.9M
Inventory	1.4M	2.3M	2.5M	3.6M	4.6M	2.7M
Other Current Assets	1.6M	3.0M	1.7M	3.8M	2.4M	1.8M
Other Stockholder Equity	6.4M	7.3M	7.7M	12.1M	15.7M	9.2M
Total Liab	38.9M	30.9M	23.1M	19.9M	41M	25.5M
Property Plant And Equipment Gross	54.8M	55.1M	90.9M	108.3M	129.8M	136.3M
Short Long Term Debt	1.8M	1.8M	1.5M	1.1M	1.2M	1.1M
Total Current Assets	27.8M	47.2M	47.3M	39.7M	38.4M	32.4M
Accumulated Other Comprehensive Income	(8.8M)	(157K)	(451K)	(278K)	(319.7K)	(335.7K)
Short Term Debt	8.8M	7.3M	2.4M	990K	2.0M	2.9M
Common Stock	3.4M	9.2M	14.0M	15.1M	18.7M	19.6M
Property Plant Equipment	54.8M	55.1M	62.8M	68.4M	78.7M	43.3M
Short Long Term Debt Total	19.5M	11.1M	6.5M	694K	10.3M	8.7M
Property Plant And Equipment Net	54.8M	55.1M	62.8M	68.4M	76.9M	52.6M
Current Deferred Revenue	3.3M	3.4M	3.8M	4.6M	6.2M	4.1M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

When determining whether Viemed Healthcare is a strong investment it is important to analyze Viemed Healthcare's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Viemed Healthcare's future performance. For an informed investment choice regarding Viemed Stock, refer to the following important reports:

How To Invest In Viemed

Details

Is Viemed Stock a good investment?

Details

What is Viemed Healthcare's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Viemed Healthcare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

For information on how to trade Viemed Stock refer to our How to Trade Viemed Stock guide.

You can also try the Stocks Directory module to find actively traded stocks across global markets.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Viemed Healthcare. If investors know Viemed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Viemed Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.425

Earnings Share

0.25

Revenue Per Share

5.534

Quarterly Revenue Growth

0.174

Return On Assets

0.0686

The market value of Viemed Healthcare is measured differently than its book value, which is the value of Viemed that is recorded on the company's balance sheet. Investors also form their own opinion of Viemed Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Viemed Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Viemed Healthcare's market value can be influenced by many factors that don't directly affect Viemed Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Viemed Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Viemed Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Viemed Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Viemed Roic vs Ev To Sales Analysis

Roic vs Ev To Sales

Roic vs Ev To Sales Correlation Analysis

Correlation Coefficient

Roic

Ev To Sales

Viemed Healthcare fundamental ratios Correlations

Viemed Healthcare Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Viemed Healthcare fundamental ratios Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Retained Earnings	+ 1.0	Total Stockholder Equity
Total Stockholder Equity	+ 0.99	Total Assets
Retained Earnings	+ 0.99	Total Assets
Property Plant Equipment	+ 0.99	Total Assets
Property Plant And Equipment Net	+ 0.99	Total Assets
Net Invested Capital	+ 0.99	Total Stockholder Equity

Net Working Capital	- 0.97	Net Debt
Net Debt	- 0.88	Cash
Net Debt	- 0.84	Total Current Assets
Net Debt	- 0.77	Retained Earnings
Net Debt	- 0.74	Total Stockholder Equity
Net Invested Capital	- 0.7	Net Debt